SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001019687-16-004777
Filing Date
2016-01-11
Accepted
2016-01-11 18:56:12
Documents
1
Period of Report
2016-01-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT okajima_f4.html 4  
1 OWNERSHIP DOCUMENT okajima_f4.xml 4 6418
  Complete submission text file 0001019687-16-004777.txt   7816
Mailing Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Issuer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MEDICINOVA, INC. 4275 EXECUTIVE SQUARE, SUITE 650 LA JOLLA CA 92037
Business Address
Okajima Masatsune (Reporting) CIK: 0001374660 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33185 | Film No.: 161337369